Type 1 diabetes mellitus Trials in Seattle, United States
Conditions / Type 1 diabetes mellitus / Seattle, United States
Type 1 diabetes mellitus has been the subject of sustained clinical investigation across multiple research sites.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07088068 | A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | RECRUITING | — |
| NCT06111586 | FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) | RECRUITING | PHASE2 |
| NCT01683266 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT02384941 | Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy | COMPLETED | PHASE3 |
| NCT06783309 | CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | RECRUITING | PHASE1/PHASE2 |
| NCT03875729 | Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab | COMPLETED | PHASE3 |
| NCT00385697 | The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus | COMPLETED | PHASE2/PHASE3 |
| NCT00920582 | Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus | TERMINATED | PHASE3 |
| NCT00229658 | An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes | COMPLETED | — |
| NCT07228117 | GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | RECRUITING | NA |